Brokers name 3 ASX shares to buy right now

Brokers have named ResMed Inc. (ASX:RMD) and these ASX shares as buys this week. Here's why they are bullish on them…

| More on:
ASX shares Hand writing Time to Buy concept clock with blue marker on transparent wipe board.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Australia's top brokers have been busy adjusting their estimates and recommendations again, leading to the release of a large number of broker notes this week.

Three broker buy ratings that have caught my eye are summarised below. Here's why brokers think these ASX 200 shares are in the buy zone:

ELMO Software Ltd (ASX: ELO)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $9.00 price target on this HR and payroll software company's shares. This follows the release of its full year results on Thursday. Although the broker notes that ELMO's guidance for FY 2021 is a little softer than the market was expecting, it believes it is positive that it is actually in a position to provide guidance. Overall, it remains very positive on its long term prospects and retains its overweight rating. I agree with Morgan Stanley and feel the post-results pullback in the ELMO share price is a buying opportunity. Especially given its growth through acquisition plans.

Nick Scali Limited (ASX: NCK)

Analysts at Citi have retained their buy rating and lifted the price target on this furniture retailer's shares to $9.80. According to the note, the broker believes that Nick Scali's first half profit guidance of 50% to 60% growth may prove conservative. In addition to this, it believes the market is overlooking its strong balance sheet which could be used for acquisitions. I think Citi makes some great points and Nick Scali could be worth considering.

ResMed Inc. (ASX: RMD)

A note out of Morgans reveals that its analysts have retained their add rating and lifted the price target on this medical device company's shares to $29.33. The broker notes that ResMed's fourth quarter profit result was ahead of its expectations. This was driven by very strong ventilator sales due to the pandemic. And although it suspects that the first half of FY 2021 will be challenging, it appears optimistic that its outlook is very positive on the other side of the pandemic. Especially given its growing installed base and its large addressable market. I agree with Morgans and believe the recent weakness in the ResMed share price is a buying opportunity.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Elmo Software. The Motley Fool Australia has recommended Elmo Software and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »